Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thyme extract + ammonium chloride is a classic herbal-chemical combination therapy used primarily as an expectorant for the treatment of coughs associated with acute and chronic respiratory diseases. The formulation combines the botanical properties of *Thymus vulgaris* with the saline expectorant effects of ammonium chloride. Thyme extract, rich in volatile oils such as thymol and carvacrol, exerts secretolytic, antispasmodic, and antimicrobial effects, facilitating the thinning of mucus and relaxation of bronchial smooth muscle. Ammonium chloride acts as a reflex expectorant by mildly irritating the gastric mucosa, which triggers a vagal reflex that increases the production of liquid bronchial secretions. This dual action reduces the viscosity of phlegm and enhances mucociliary clearance, making it easier for patients to expectorate. It is most commonly found in syrup form and has been a staple of pharmacopoeias in Eastern Europe and Central Asia for decades.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on thyme extract + ammonium chloride.